UPDATE 1-CVS urges cost controls for new cholesterol, specialty drugs
February 17, 2015 at 12:04 PM EST
Feb 17 (Reuters) - CVS Health on Monday warned that costs of a potent new class of cholesterol treatments and other specialty drugs in development could eclipse those of expensive new medicines and overwhelm the healthcare system "if rigid cost control mechanisms are not put in place."